FlowAid opens enrollment for a new clinical trial of its FlowAid FA100 SCCD in the New York Tri-State area27 November,2017
FlowAid Medical Technologies Inc. is pleased to announce the opening of enrollment in a clinical trial of its FlowAid FA100 SCCD in the New York Tri-State area. If you suffer from Painful Diabetic Peripheral Neuropathy (DPN), are interested in learning more and participating in this study, please contact us at email@example.com.
The FA100 device is a portable noninvasive electric muscle pump. The device is meant for daily home use, and does not interfere with any activities or schedule. The trial will last one month and requires an introductory visit, as well as one closing visit, with the principal investigators.
No medications are being evaluated as part of this study.